Mapping the Longitudinal, Multidimensional Impact of MS in Relation to Variables Indicative of Neurological Reserve
NCT06410326 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2600
Last updated 2024-05-13
Summary
Some MS patients quickly accumulate neurological deficits, while others remain well for decades. Even though associations with age, sex, health behaviors, comorbidities and social determinants of health are widely acknowledged, the clinical heterogeneity in MS is poorly understood and variables with a robust prognostic value are lacking. Recent data suggest a key role for resilience in the central nervous system, potentially supporting the concept of neurological reserve in MS.
Conditions
Sponsors & Collaborators
-
Vrije Universiteit Brussel
collaborator OTHER -
National MS Center Melsbroek
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-04-01
- Primary Completion
- 2024-04-01
- Completion
- 2024-04-01
Countries
- Belgium
Study Locations
More Related Trials
-
Assessment of Walking-related Fatigability in Patients With Multiple Sclerosis.
NCT03860675 ·Status: COMPLETED ·Phase: NA
-
Pathological Basis of MRI Signal Changes in Multiple Sclerosis
NCT02659956 ·Status: RECRUITING
-
BrainAgeMS - a Comparative Study of Brain Aging in Healthy and Patients With Multiple Sclerosis
NCT06221631 ·Status: RECRUITING
-
Multiparametric Assessment to Investigate Prognostic Factors for Disease Evolution a nd Evolutionary Patterns of Cognitive Status in RRMS
NCT05510817 ·Status: RECRUITING ·Phase: NA
-
Artificial Intelligence in Predicting Progression in Multiple Sclerosis Study
NCT05426980 ·Status: COMPLETED
-
Accuracy of Motor Performance Perception in Multiple Sclerosis
NCT07175792 ·Status: RECRUITING
-
Assessment of Patients With Multiple Sclerosis (MS)
NCT00001156 ·Status: COMPLETED
-
Multiple Sclerosis: Associated Cardiometabolic Risks and Impact of Exercise Therapy
NCT02466165 ·Status: COMPLETED ·Phase: NA
-
Clinical Impact Through AI-assisted MS Care - A Retrospective Multi-center Observational Study.
NCT06280755 ·Status: RECRUITING
-
Development of Digital Biomarkers in Multiple Sclerosis: Validation Study 2
NCT06309173 ·Status: WITHDRAWN
-
A Multi-center, Multi-regional Observational Study to Test the Responsiveness of the Validated MusiQoL (Multiple Sclerosis International Quality of Life Questionnaire) Instrument to EDSS Status Changes in Any Form of Multiple Sclerosis (MS) in Patients With or Without Treatment
NCT00702065 ·Status: COMPLETED
-
Genes and Environment in Multiple Sclerosis
NCT01353547 ·Status: RECRUITING
-
Relating Genetic and Environmental Risk Scores to Multiple Sclerosis Susceptibility
NCT01617395 ·Status: COMPLETED
-
Psychometric Properties Mobility Measures MS
NCT02339688 ·Status: COMPLETED ·Phase: NA
-
Risk Factors in Early Multiple Sclerosis
NCT03586986 ·Status: UNKNOWN
-
Clinical Disease Activity With Long Term Natalizumab Treatment
NCT02677077 ·Status: COMPLETED
-
The MS-CEBA Study: Determining Cognitive, Energetic, Behavioural and Affective (CEBA) Profiles in Multiple Sclerosis
NCT06016309 ·Status: RECRUITING
-
Care in Multiple Sclerosis (MS)
NCT07011914 ·Status: RECRUITING
-
Cerebrovascular Changes in Multiple Sclerosis Patients
NCT03709290 ·Status: UNKNOWN
-
Magnetic Resonance Imaging (MRI) to Evaluate Activity of Multiple Sclerosis (MS)
NCT00001248 ·Status: RECRUITING
-
Multimodal Imaging Signatures of the Biological Mechanisms Underlying Neurodegeneration in Multiple Sclerosis
NCT05633875 ·Status: RECRUITING
-
CogMS - A Real-world Study Into Cognitive Impairment in People With Multiple Sclerosis
NCT05671055 ·Status: COMPLETED
-
Barriers to Physical Activity in People With MS
NCT04746807 ·Status: COMPLETED
-
The Gut Microbiome in Adult Multiple Sclerosis
NCT04929145 ·Status: COMPLETED
-
Gilenya's Impact on Cognitive Function and Thalamic Volumes
NCT03243721 ·Status: COMPLETED ·Phase: NA